|Benefit-Cost Summary Statistics Per Participant|
|Taxpayers||$1,015||Benefits minus costs||($27,107)|
|Participants||($586)||Benefit to cost ratio||($0.41)|
|Others||$518||Chance the program will produce|
|Indirect||($8,845)||benefits greater than the costs||13 %|
|Net program cost||($19,208)|
|Benefits minus cost||($27,107)|
|Meta-Analysis of Program Effects|
|Outcomes measured||Treatment age||No. of effect sizes||Treatment N||Adjusted effect sizes(ES) and standard errors(SE) used in the benefit - cost analysis||Unadjusted effect size (random effects model)|
|First time ES is estimated||Second time ES is estimated|
Any criminal conviction according to court records, sometimes measured through charges, arrests, incarceration, or self-report.
Alcohol use disorder
Clinical diagnosis of alcohol use disorder or symptoms measured on a validated scale.
Illicit drug use disorder
Clinical diagnosis of illicit drug use disorder or symptoms measured on a validated scale. When possible, we exclude cannabis/marijuana use disorder from this outcome.
How well individuals (typically those who are developmentally disabled or seriously mentally ill) have adapted to activities of daily living.
Hospital admission, for any reason.
Admission to a psychiatric ward or hospital.
A lack of stable housing, often measured through self-report of conditions like living on streets or in shelters in a given time period.
Emergency department visits
Whether someone visited the emergency department, or the number of times they visited the emergency department.
Mental health symptoms (such as symptoms of psychosis) in individuals with serious mental illness, measured on a validated scale.
|Detailed Monetary Benefit Estimates Per Participant|
|Affected outcome:||Resulting benefits:1||Benefits accrue to:|
|Crime||Criminal justice system||$101||$0||$188||$50||$339|
|Alcohol use disorder||Labor market earnings associated with alcohol abuse or dependence||($260)||($610)||$0||$130||($740)|
|Health care associated with alcohol abuse or dependence||($6)||($1)||($6)||($3)||($16)|
|Property loss associated with alcohol abuse or dependence||$0||($1)||($1)||$0||($2)|
|Mortality associated with alcohol||$0||($1)||$0||($8)||($9)|
|Hospitalization||Health care associated with general hospitalization||$35||$2||$35||$18||$89|
|Hospitalization (psychiatric)||Health care associated with psychiatric hospitalization||$1,108||$15||$250||$554||$1,928|
|Emergency department visits||Health care associated with emergency department visits||$36||$10||$53||$18||$118|
|Program cost||Adjustment for deadweight cost of program||$0||$0||$0||($9,604)||($9,604)|
|Detailed Annual Cost Estimates Per Participant|
|Annual cost||Year dollars||Summary|
|Program costs||$14,000||2013||Present value of net program costs (in 2018 dollars)||($19,208)|
|Comparison costs||$4,482||2013||Cost range (+ or -)||10 %|
Benefits Minus Costs
Benefits by Perspective
Taxpayer Benefits by Source of Value
|Benefits Minus Costs Over Time (Cumulative Discounted Dollars)|
|The graph above illustrates the estimated cumulative net benefits per-participant for the first fifty years beyond the initial investment in the program. We present these cash flows in discounted dollars. If the dollars are negative (bars below $0 line), the cumulative benefits do not outweigh the cost of the program up to that point in time. The program breaks even when the dollars reach $0. At this point, the total benefits to participants, taxpayers, and others, are equal to the cost of the program. If the dollars are above $0, the benefits of the program exceed the initial investment.|
Audini, B., Marks, I. M., Lawrence, R.E., Connolly, J., & Watts, V. (1994). Home-based versus out-patient/in-patient care for people with serious mental illness. The British Journal of Psychiatry : the Journal of Mental Science, 165(2), 204-210.
Bond, G.R., Miller, L.D., Krumwied, R.D., & Ward, R.S. (1988). Assertive case management in three CMHCs: A controlled study. Hospital and Community Psychiatry, 39(4), 411-418.
Bond, G.R., Witheridge, T.F., Dincin, J., Wasmer, D., Webb, J., & DeGraaf-Kaser, R. (1990). Assertive community treatment for frequent users of psychiatric hospitals in a large city: a controlled study. American Journal of Community Psychology, 18(6), 865-891.
Bush, C.T., Langford, M.W., Rosen, P., & Gott, W. (1990). Operation outreach: Intensive case management for severely psychiatrically disabled adults. Hospital and Community Psychiatry, 41(6), 647-649.
Chandler, D., Meisel, J., Hu, T. W., McGowen, M., & Madison, K. (1996). Client outcomes in a three-year controlled study of an integrated service agency model. Psychiatric Services, 47(12), 1337-1343.
Clarke, G. N., Herinckx, H. A., Kinney, R. F., Paulson, R. I., Cutler, D. L., Lewis, K., & Oxman, E. (2000). Psychiatric hospitalizations, arrests, emergency room visits, and homelessness of clients with serious and persistent mental illness: findings from a randomized trial of two ACT programs vs. usual care. Mental Health Services Research, 2(3),155-164.
Drake, R. E., McHugo, G. J., Clark, R. E., Teague, G. B., Xie, H., Miles, K., & Ackerson, T. H. (1998). Assertive community treatment for patients with co-occurring severe mental illness and substance use disorder: A clinical trial. American Journal of Orthopsychiatry, 68(2), 201-215.
Essock, S.M., & Kontos, N. (1995). Implementing assertive community treatment teams. Psychiatric Services, 46(7), 679-683.
Essock, S.M., Mueser, K.T., Drake, R.E., Covell, N.H., McHugo, G.J., Frisman, L.K., Kontos, N.J., . . . Swain, K. (2006). Comparison of ACT and standard case management for delivering integrated treatment for co-occurring disorders. Psychiatric Services, 57(2), 185-196.
Fekete, D.M., Bond, G.R., McDonel, E.C., Salyers, M.P., Chen, A., & Miller, L. (1998). Rural assertive community treatment: a field experiment. Psychiatric Rehabilitation Journal, 21(4), 371-379.
Hamernik, E., & Pakenham, K. I. (1999). Assertive Community Treatment for persons with severe mental disorders: A controlled treatment outcome study. Behaviour Change, 16(4), 259-268.
Harrison-Read, P., Lucas, B., Tyrer, P., Ray, J., Shipley, K., Simmonds, S., . . . Hickman, M. (2002). Heavy users of acute psychiatric beds: Randomized controlled trial of enhanced community management in an outer London borough. Psychological Medicine, 32(3), 403-416.
Jerrell, J.M. (1995). Toward managed care for persons with severe mental illness: implications from a cost-effectiveness study. Health Affairs, 14(3), 197-207.
Killaspy, H., Bebbington, P., Blizard, R., Johnson, S., Nolan, F., Pilling, S., & King, M. (2006). The REACT study: randomised evaluation of assertive community treatment in north London. British Medical Journal, 7545, 815-818.
Killaspy, H., Kingett, S., Bebbington, P., Blizard, R., Johnson, S., Nolan, F., Pilling, S., . . . King, M. (2009). Randomised evaluation of assertive community treatment: 3-year outcomes. The British Journal of Psychiatry, 195(1), 81-82.
Korr, W.S., & Joseph, A. (1995). Housing the Homeless Mentally Ill: Findings from Chicago. Journal of Social Service Research, 21(1), 53-68.
Lehman, A.F., Dixon, L.B., Kernan, E., DeForge, B.R., & Postrado, L.T. (1997). A randomized trial of assertive community treatment for homeless persons with severe mental illness. Archives of General Psychiatry, 54(11), 1038-1043.
Morrissey, J.P., Domino, M.E., & Cuddeback, G.S. (2013). Assessing the effectiveness of recovery-oriented ACT in reducing state psychiatric hospital use. Psychiatric Services, 64(4), 303-311.
Morse, G.A., Calsyn, R.J., Allen, G., Tempelhoff, B., & Smith, R. (1992). Experimental comparison of the effects of three treatment programs for homeless mentally ill people. Hospital and Community Psychiatry, 43(10), 1005-1010.
Morse, G.A., Calsyn, R.J., Klinkernberg, W.D., Trusty, M.L., Gerber, F., . . . Ahmad, L. (1997). Three Types of Case Management for Homeless Mentally ifi Persons. Psychiatric Services, 48(4), 497-503.
Morse, G.A., Calsyn, R.J., Dean, K.W., Helminiak, T.W., Wolff, N., Drake, R.E., Yonker, R.D., . . . McCudden, S. (2006). Treating homeless clients with severe mental illness and substance use disorders: Costs and outcomes. Community Mental Health Journal, 42(4), 377-404.
Rosenheck, R., Neale, M., Leaf, P., Milstein, R., & Frisman, L. (1995). Multisite experimental cost study of intensive community care. Schizophrenia Bulletin, 21(1), 129-140.
Rosenheck, R., Kasprow, W., Frisman, L., & Liu-Mares, W. (2003). Cost-effectiveness of supported housing for homeless persons with mental illness. Archives of General Psychiatry, 60(9), 940-951.
Salkever, D., Domino, M.E., Burns, B.J., Santos, A.B., Deci, P.A., Dias, J., Wagner, H.R., . . . Paolone, J. (1999). Assertive community treatment for people with severe mental illness: the effect on hospital use and costs. Health Services Research, 34(2), 577-601.
Sytema, S., Wunderink, L., Bloemers, W., Roorda, L., & Wiersma, D. (2007). Assertive community treatment in the Netherlands: a randomized controlled trial. Acta Psychiatrica Scandinavica, 116(2), 105-112.
Test, M.A., Knoedler, W.H., Allness, D.J., et al. (1991). Long-term community care through an assertive continuous treatment team,. In. Schultz, C.T (Ed.), Advances in Neuropsychiatry and Psychopharmacology: Schizophrenia Research, Vol. 1 (pp.239-246).
Test, M.A., Knoedler, W.H., Allness, D.J., Burke, S.S., Brown, R.L., & Wallisch, L.S. (1991). Long-term community care through an assertive continuous treatment team. In Schultz, C.T. (Ed.), Advances in Neuropsychiatry and Psychopharmacology: Schizophrenia Research, Vol. 1 (pp.239-246). New York, NY: Raven Press, Publishers.